[Federal Register Volume 72, Number 62 (Monday, April 2, 2007)]
[Notices]
[Page 15697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-6009]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Peer Review of Division of HIV/AIDS Prevention 
Intramural International Biomedical Interventional Research in 
Thailand, Kenya, Botswana and Cameroon

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Times and Dates: 8 a.m.-5 p.m., May 2, 2007 (Closed) 8 a.m.-5 
p.m., May 3, 2007 (Closed).

    Place: Corporate Square, 9 Corporate Boulevard, Suite 100, 
Atlanta, GA 30329, telephone 404-679-7900.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of the ``Division of HIV/AIDS Prevention 
Intramural International Biomedical Interventional Research in 
Thailand, Kenya, Botswana and Cameroon.''
    Contact Person for More Information: Elise M. Beltrami, M.D., 
M.P.H., Designated Federal Official, National Center for 
Preparedness, Detection and Control of Infectious Diseases, Division 
of Healthcare Quality Promotion, CDC, 1600 Clifton Road N.E., 
Mailstop A-31, Atlanta, GA 30333, Telephone 404-639-4271.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: March 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-6009 Filed 3-30-07; 8:45 am]
BILLING CODE 4163-18-P